English
简体中文
Total: £ 56.28
Published Date: 2024-12-06 | Pages: 109 | Tables: 178 | Medical Care
Advanced Therapy Based on Gene is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global market for DNA Medicine Based on DNA Modification was estimated to be worth US$ 9063 million in 2023 and is forecast to a readjusted size of US$ 34850 million by 2030 with a CAGR of 20.2% during the forecast period 2024-2030
The advanced therapy based on gene market is driven by the potential to revolutionize healthcare by offering personalized and targeted treatments for genetic disorders and other diseases. Advanced therapy based on gene includes gene therapy, cell therapy, and gene editing techniques, which aim to modify or replace faulty genes to treat or cure diseases at the genetic level. The rise in the understanding of genetic mechanisms and advancements in biotechnology and genetic engineering contribute to market growth as these therapies hold promise for previously untreatable conditions. Moreover, increasing investment in research and clinical trials and the support from regulatory agencies for accelerated approval further boost the development and commercialization of advanced gene therapies. However, the market also faces challenges, including the complexity of manufacturing and delivering gene-based therapies, safety concerns related to viral vectors and off-target effects in gene editing, and high treatment costs. Additionally, addressing regulatory requirements and ensuring accessibility and affordability of advanced gene therapies can pose obstacles for broader adoption. To succeed, companies must focus on research and development to advance the safety and efficacy of gene-based therapies, collaborate with healthcare stakeholders to build robust infrastructure, and address the challenges to fully realize the transformative potential of advanced therapy based on gene in modern medicine.
Report Scope
This report aims to provide a comprehensive presentation of the global market for DNA Medicine Based on DNA Modification, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of DNA Medicine Based on DNA Modification by region & country, by Type, and by Application.
The DNA Medicine Based on DNA Modification market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Medicine Based on DNA Modification.
Market Segmentation
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type:
Viral
Non-viral
Segment by Application
Neurological Diseases
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of DNA Medicine Based on DNA Modification manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of DNA Medicine Based on DNA Modification in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of DNA Medicine Based on DNA Modification in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 DNA Medicine Based on DNA Modification Product Introduction
1.2 Global DNA Medicine Based on DNA Modification Market Size Forecast
1.3 DNA Medicine Based on DNA Modification Market Trends & Drivers
1.3.1 DNA Medicine Based on DNA Modification Industry Trends
1.3.2 DNA Medicine Based on DNA Modification Market Drivers & Opportunity
1.3.3 DNA Medicine Based on DNA Modification Market Challenges
1.3.4 DNA Medicine Based on DNA Modification Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global DNA Medicine Based on DNA Modification Players Revenue Ranking (2023)
2.2 Global DNA Medicine Based on DNA Modification Revenue by Company (2019-2024)
2.3 Key Companies DNA Medicine Based on DNA Modification Manufacturing Base Distribution and Headquarters
2.4 Key Companies DNA Medicine Based on DNA Modification Product Offered
2.5 Key Companies Time to Begin Mass Production of DNA Medicine Based on DNA Modification
2.6 DNA Medicine Based on DNA Modification Market Competitive Analysis
2.6.1 DNA Medicine Based on DNA Modification Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by DNA Medicine Based on DNA Modification Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Medicine Based on DNA Modification as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Viral
3.1.2 Non-viral
3.2 Global DNA Medicine Based on DNA Modification Sales Value by Type
3.2.1 Global DNA Medicine Based on DNA Modification Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global DNA Medicine Based on DNA Modification Sales Value, by Type (2019-2030)
3.2.3 Global DNA Medicine Based on DNA Modification Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Neurological Diseases
4.1.2 Cancer
4.1.3 Other
4.2 Global DNA Medicine Based on DNA Modification Sales Value by Application
4.2.1 Global DNA Medicine Based on DNA Modification Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global DNA Medicine Based on DNA Modification Sales Value, by Application (2019-2030)
4.2.3 Global DNA Medicine Based on DNA Modification Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global DNA Medicine Based on DNA Modification Sales Value by Region
5.1.1 Global DNA Medicine Based on DNA Modification Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global DNA Medicine Based on DNA Modification Sales Value by Region (2019-2024)
5.1.3 Global DNA Medicine Based on DNA Modification Sales Value by Region (2025-2030)
5.1.4 Global DNA Medicine Based on DNA Modification Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America DNA Medicine Based on DNA Modification Sales Value, 2019-2030
5.2.2 North America DNA Medicine Based on DNA Modification Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe DNA Medicine Based on DNA Modification Sales Value, 2019-2030
5.3.2 Europe DNA Medicine Based on DNA Modification Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific DNA Medicine Based on DNA Modification Sales Value, 2019-2030
5.4.2 Asia Pacific DNA Medicine Based on DNA Modification Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America DNA Medicine Based on DNA Modification Sales Value, 2019-2030
5.5.2 South America DNA Medicine Based on DNA Modification Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa DNA Medicine Based on DNA Modification Sales Value, 2019-2030
5.6.2 Middle East & Africa DNA Medicine Based on DNA Modification Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions DNA Medicine Based on DNA Modification Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions DNA Medicine Based on DNA Modification Sales Value
6.3 United States
6.3.1 United States DNA Medicine Based on DNA Modification Sales Value, 2019-2030
6.3.2 United States DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
6.3.3 United States DNA Medicine Based on DNA Modification Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe DNA Medicine Based on DNA Modification Sales Value, 2019-2030
6.4.2 Europe DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe DNA Medicine Based on DNA Modification Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China DNA Medicine Based on DNA Modification Sales Value, 2019-2030
6.5.2 China DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
6.5.3 China DNA Medicine Based on DNA Modification Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan DNA Medicine Based on DNA Modification Sales Value, 2019-2030
6.6.2 Japan DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan DNA Medicine Based on DNA Modification Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea DNA Medicine Based on DNA Modification Sales Value, 2019-2030
6.7.2 South Korea DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea DNA Medicine Based on DNA Modification Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia DNA Medicine Based on DNA Modification Sales Value, 2019-2030
6.8.2 Southeast Asia DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia DNA Medicine Based on DNA Modification Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India DNA Medicine Based on DNA Modification Sales Value, 2019-2030
6.9.2 India DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
6.9.3 India DNA Medicine Based on DNA Modification Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Biogen
7.1.1 Biogen Profile
7.1.2 Biogen Main Business
7.1.3 Biogen DNA Medicine Based on DNA Modification Products, Services and Solutions
7.1.4 Biogen DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.1.5 Biogen Recent Developments
7.2 Novartis
7.2.1 Novartis Profile
7.2.2 Novartis Main Business
7.2.3 Novartis DNA Medicine Based on DNA Modification Products, Services and Solutions
7.2.4 Novartis DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.2.5 Novartis Recent Developments
7.3 Gilead Sciences
7.3.1 Gilead Sciences Profile
7.3.2 Gilead Sciences Main Business
7.3.3 Gilead Sciences DNA Medicine Based on DNA Modification Products, Services and Solutions
7.3.4 Gilead Sciences DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.3.5 Sarepta Therapeutics Recent Developments
7.4 Sarepta Therapeutics
7.4.1 Sarepta Therapeutics Profile
7.4.2 Sarepta Therapeutics Main Business
7.4.3 Sarepta Therapeutics DNA Medicine Based on DNA Modification Products, Services and Solutions
7.4.4 Sarepta Therapeutics DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.4.5 Sarepta Therapeutics Recent Developments
7.5 Alnylam Pharmaceuticals
7.5.1 Alnylam Pharmaceuticals Profile
7.5.2 Alnylam Pharmaceuticals Main Business
7.5.3 Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Products, Services and Solutions
7.5.4 Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.5.5 Alnylam Pharmaceuticals Recent Developments
7.6 Amgen
7.6.1 Amgen Profile
7.6.2 Amgen Main Business
7.6.3 Amgen DNA Medicine Based on DNA Modification Products, Services and Solutions
7.6.4 Amgen DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.6.5 Amgen Recent Developments
7.7 Spark Therapeutics
7.7.1 Spark Therapeutics Profile
7.7.2 Spark Therapeutics Main Business
7.7.3 Spark Therapeutics DNA Medicine Based on DNA Modification Products, Services and Solutions
7.7.4 Spark Therapeutics DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.7.5 Spark Therapeutics Recent Developments
7.8 Akcea Therapeutics
7.8.1 Akcea Therapeutics Profile
7.8.2 Akcea Therapeutics Main Business
7.8.3 Akcea Therapeutics DNA Medicine Based on DNA Modification Products, Services and Solutions
7.8.4 Akcea Therapeutics DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.8.5 Akcea Therapeutics Recent Developments
7.9 Sunway Biotech
7.9.1 Sunway Biotech Profile
7.9.2 Sunway Biotech Main Business
7.9.3 Sunway Biotech DNA Medicine Based on DNA Modification Products, Services and Solutions
7.9.4 Sunway Biotech DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.9.5 Sunway Biotech Recent Developments
7.10 SIBIONO
7.10.1 SIBIONO Profile
7.10.2 SIBIONO Main Business
7.10.3 SIBIONO DNA Medicine Based on DNA Modification Products, Services and Solutions
7.10.4 SIBIONO DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.10.5 SIBIONO Recent Developments
7.11 AnGes
7.11.1 AnGes Profile
7.11.2 AnGes Main Business
7.11.3 AnGes DNA Medicine Based on DNA Modification Products, Services and Solutions
7.11.4 AnGes DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.11.5 AnGes Recent Developments
7.12 Orchard Therapeutics
7.12.1 Orchard Therapeutics Profile
7.12.2 Orchard Therapeutics Main Business
7.12.3 Orchard Therapeutics DNA Medicine Based on DNA Modification Products, Services and Solutions
7.12.4 Orchard Therapeutics DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.12.5 Orchard Therapeutics Recent Developments
7.13 Human Stem Cells Institute
7.13.1 Human Stem Cells Institute Profile
7.13.2 Human Stem Cells Institute Main Business
7.13.3 Human Stem Cells Institute DNA Medicine Based on DNA Modification Products, Services and Solutions
7.13.4 Human Stem Cells Institute DNA Medicine Based on DNA Modification Revenue (US$ Million) & (2019-2024)
7.13.5 Human Stem Cells Institute Recent Developments
8 Industry Chain Analysis
8.1 DNA Medicine Based on DNA Modification Industrial Chain
8.2 DNA Medicine Based on DNA Modification Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 DNA Medicine Based on DNA Modification Sales Model
8.5.2 Sales Channel
8.5.3 DNA Medicine Based on DNA Modification Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. DNA Medicine Based on DNA Modification Market Trends
Table 2. DNA Medicine Based on DNA Modification Market Drivers & Opportunity
Table 3. DNA Medicine Based on DNA Modification Market Challenges
Table 4. DNA Medicine Based on DNA Modification Market Restraints
Table 5. Global DNA Medicine Based on DNA Modification Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global DNA Medicine Based on DNA Modification Revenue Market Share by Company (2019-2024)
Table 7. Key Companies DNA Medicine Based on DNA Modification Manufacturing Base Distribution and Headquarters
Table 8. Key Companies DNA Medicine Based on DNA Modification Product Type
Table 9. Key Companies Time to Begin Mass Production of DNA Medicine Based on DNA Modification
Table 10. Global DNA Medicine Based on DNA Modification Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Medicine Based on DNA Modification as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global DNA Medicine Based on DNA Modification Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global DNA Medicine Based on DNA Modification Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global DNA Medicine Based on DNA Modification Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global DNA Medicine Based on DNA Modification Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global DNA Medicine Based on DNA Modification Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global DNA Medicine Based on DNA Modification Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global DNA Medicine Based on DNA Modification Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global DNA Medicine Based on DNA Modification Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global DNA Medicine Based on DNA Modification Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global DNA Medicine Based on DNA Modification Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global DNA Medicine Based on DNA Modification Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global DNA Medicine Based on DNA Modification Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global DNA Medicine Based on DNA Modification Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global DNA Medicine Based on DNA Modification Sales Value by Region (2019-2024) & (%)
Table 27. Global DNA Medicine Based on DNA Modification Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions DNA Medicine Based on DNA Modification Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions DNA Medicine Based on DNA Modification Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions DNA Medicine Based on DNA Modification Sales Value, (2025-2030) & (US$ Million)
Table 31. Biogen Basic Information List
Table 32. Biogen Description and Business Overview
Table 33. Biogen DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 34. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of Biogen (2019-2024)
Table 35. Biogen Recent Developments
Table 36. Novartis Basic Information List
Table 37. Novartis Description and Business Overview
Table 38. Novartis DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 39. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of Novartis (2019-2024)
Table 40. Novartis Recent Developments
Table 41. Gilead Sciences Basic Information List
Table 42. Gilead Sciences Description and Business Overview
Table 43. Gilead Sciences DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 44. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of Gilead Sciences (2019-2024)
Table 45. Gilead Sciences Recent Developments
Table 46. Sarepta Therapeutics Basic Information List
Table 47. Sarepta Therapeutics Description and Business Overview
Table 48. Sarepta Therapeutics DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 49. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of Sarepta Therapeutics (2019-2024)
Table 50. Sarepta Therapeutics Recent Developments
Table 51. Alnylam Pharmaceuticals Basic Information List
Table 52. Alnylam Pharmaceuticals Description and Business Overview
Table 53. Alnylam Pharmaceuticals DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 54. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of Alnylam Pharmaceuticals (2019-2024)
Table 55. Alnylam Pharmaceuticals Recent Developments
Table 56. Amgen Basic Information List
Table 57. Amgen Description and Business Overview
Table 58. Amgen DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 59. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of Amgen (2019-2024)
Table 60. Amgen Recent Developments
Table 61. Spark Therapeutics Basic Information List
Table 62. Spark Therapeutics Description and Business Overview
Table 63. Spark Therapeutics DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 64. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of Spark Therapeutics (2019-2024)
Table 65. Spark Therapeutics Recent Developments
Table 66. Akcea Therapeutics Basic Information List
Table 67. Akcea Therapeutics Description and Business Overview
Table 68. Akcea Therapeutics DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 69. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of Akcea Therapeutics (2019-2024)
Table 70. Akcea Therapeutics Recent Developments
Table 71. Sunway Biotech Basic Information List
Table 72. Sunway Biotech Description and Business Overview
Table 73. Sunway Biotech DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 74. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of Sunway Biotech (2019-2024)
Table 75. Sunway Biotech Recent Developments
Table 76. SIBIONO Basic Information List
Table 77. SIBIONO Description and Business Overview
Table 78. SIBIONO DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 79. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of SIBIONO (2019-2024)
Table 80. SIBIONO Recent Developments
Table 81. AnGes Basic Information List
Table 82. AnGes Description and Business Overview
Table 83. AnGes DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 84. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of AnGes (2019-2024)
Table 85. AnGes Recent Developments
Table 86. Orchard Therapeutics Basic Information List
Table 87. Orchard Therapeutics Description and Business Overview
Table 88. Orchard Therapeutics DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 89. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of Orchard Therapeutics (2019-2024)
Table 90. Orchard Therapeutics Recent Developments
Table 91. Human Stem Cells Institute Basic Information List
Table 92. Human Stem Cells Institute Description and Business Overview
Table 93. Human Stem Cells Institute DNA Medicine Based on DNA Modification Products, Services and Solutions
Table 94. Revenue (US$ Million) in DNA Medicine Based on DNA Modification Business of Human Stem Cells Institute (2019-2024)
Table 95. Human Stem Cells Institute Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. DNA Medicine Based on DNA Modification Downstream Customers
Table 99. DNA Medicine Based on DNA Modification Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. DNA Medicine Based on DNA Modification Product Picture
Figure 2. Global DNA Medicine Based on DNA Modification Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global DNA Medicine Based on DNA Modification Sales Value (2019-2030) & (US$ Million)
Figure 4. DNA Medicine Based on DNA Modification Report Years Considered
Figure 5. Global DNA Medicine Based on DNA Modification Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by DNA Medicine Based on DNA Modification Revenue in 2023
Figure 7. DNA Medicine Based on DNA Modification Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Viral Picture
Figure 9. Non-viral Picture
Figure 10. Global DNA Medicine Based on DNA Modification Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global DNA Medicine Based on DNA Modification Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Neurological Diseases
Figure 13. Product Picture of Cancer
Figure 14. Product Picture of Other
Figure 15. Global DNA Medicine Based on DNA Modification Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global DNA Medicine Based on DNA Modification Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America DNA Medicine Based on DNA Modification Sales Value (2019-2030) & (US$ Million)
Figure 18. North America DNA Medicine Based on DNA Modification Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe DNA Medicine Based on DNA Modification Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe DNA Medicine Based on DNA Modification Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific DNA Medicine Based on DNA Modification Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific DNA Medicine Based on DNA Modification Sales Value by Country (%), 2023 VS 2030
Figure 23. South America DNA Medicine Based on DNA Modification Sales Value (2019-2030) & (US$ Million)
Figure 24. South America DNA Medicine Based on DNA Modification Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa DNA Medicine Based on DNA Modification Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa DNA Medicine Based on DNA Modification Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions DNA Medicine Based on DNA Modification Sales Value (%), (2019-2030)
Figure 28. United States DNA Medicine Based on DNA Modification Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
Figure 30. United States DNA Medicine Based on DNA Modification Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe DNA Medicine Based on DNA Modification Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe DNA Medicine Based on DNA Modification Sales Value by Application (%), 2023 VS 2030
Figure 34. China DNA Medicine Based on DNA Modification Sales Value, (2019-2030) & (US$ Million)
Figure 35. China DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
Figure 36. China DNA Medicine Based on DNA Modification Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan DNA Medicine Based on DNA Modification Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan DNA Medicine Based on DNA Modification Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea DNA Medicine Based on DNA Modification Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea DNA Medicine Based on DNA Modification Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia DNA Medicine Based on DNA Modification Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia DNA Medicine Based on DNA Modification Sales Value by Application (%), 2023 VS 2030
Figure 46. India DNA Medicine Based on DNA Modification Sales Value, (2019-2030) & (US$ Million)
Figure 47. India DNA Medicine Based on DNA Modification Sales Value by Type (%), 2023 VS 2030
Figure 48. India DNA Medicine Based on DNA Modification Sales Value by Application (%), 2023 VS 2030
Figure 49. DNA Medicine Based on DNA Modification Industrial Chain
Figure 50. DNA Medicine Based on DNA Modification Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
